CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Aimmune Therapeutics, Inc.  (AIMT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Aimmune Therapeutics's Quick Ratio

AIMT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

AIMT Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change 208.69 % 92.2 % 124.6 % 282.16 % 75.65 %
Y / Y Cash & cash equivalent Change 40.46 % 36.59 % 29.76 % -30.64 % 188.82 %
Quick Ratio MRQ 13.16 24.09 21.74 12.68 28.91
Overall Ranking # 196 # 114 # 114 # 115 # 0
Seq. Current Liabilities Change 76.46 % -10.72 % -3.35 % 102.72 % 9.87 %
Seq. Cash & cash equivalent Change -3.62 % -1.08 % 65.69 % -11.08 % -6.27 %



Quick Ratio second quarter 2017 Comment
Due to increase in Current Liabilities in the second quarter 2017, Quick Ratio fell to 13.16 below Aimmune Therapeutics, Inc. average.

Within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Quick Ratio than Aimmune Therapeutics in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AIMT Segments?
See Quick Ratio AIMT on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 60
Overall Market # 196


Quick Ratio Statistics
High Average Low
69.87 28.84 12.68
(Sep 30 2015)   (Sep 30 2016)


You need to upgrade your Flash Player


Financial Statements
Aimmune Therapeutics's Current Liabilities $ 18 Millions Visit AIMT's Balance sheet
Aimmune Therapeutics's Cash & cash equivalent $ 237 Millions Visit AIMT's Balance sheet
Source of AIMT's Sales Visit AIMT's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Kindred Biosciences, Inc.  29.17 $ 73.545  Millions$ 2.521  Millions
Inotek Pharmaceuticals Corporation  27.08 $ 108.754  Millions$ 4.016  Millions
Corvus Pharmaceuticals, Inc.  26.66 $ 110.326  Millions$ 4.138  Millions
Prothena Corp Plc  25.09 $ 471.729  Millions$ 18.800  Millions
Achillion Pharmaceuticals Inc  25.00 $ 350.455  Millions$ 14.020  Millions
Flex Pharma, Inc.  24.76 $ 47.123  Millions$ 1.903  Millions
Dermira, Inc.  24.15 $ 690.761  Millions$ 28.603  Millions
Endocyte Inc  22.60 $ 118.395  Millions$ 5.239  Millions
Glycomimetics Inc  21.88 $ 119.200  Millions$ 5.447  Millions
Sierra Oncology, Inc.  21.13 $ 116.699  Millions$ 5.523  Millions
Chimerix Inc  19.12 $ 148.528  Millions$ 7.768  Millions
Catalyst Pharmaceuticals, Inc.  19.09 $ 35.131  Millions$ 1.840  Millions
Tonix Pharmaceuticals Holding Corp.  18.78 $ 34.366  Millions$ 1.830  Millions
Paratek Pharmaceuticals, Inc.  18.75 $ 175.453  Millions$ 9.357  Millions
Flexion Therapeutics Inc  18.17 $ 359.859  Millions$ 19.805  Millions
Enanta Pharmaceuticals Inc  17.26 $ 192.015  Millions$ 11.122  Millions
Concert Pharmaceuticals, Inc.  17.02 $ 103.420  Millions$ 6.077  Millions
Aquinox Pharmaceuticals, Inc  16.15 $ 131.277  Millions$ 8.128  Millions
Dynavax Technologies Corp  16.14 $ 126.961  Millions$ 7.865  Millions
Medicinova Inc  16.12 $ 22.890  Millions$ 1.420  Millions
Spring Bank Pharmaceuticals, Inc.  15.91 $ 56.379  Millions$ 3.544  Millions
Otonomy, Inc.  15.83 $ 150.532  Millions$ 9.510  Millions
Aduro Biotech, Inc.  15.19 $ 377.243  Millions$ 24.831  Millions
Ovid Therapeutics Inc.  15.08 $ 106.546  Millions$ 7.065  Millions
Beigene, Ltd.  14.80 $ 407.430  Millions$ 27.525  Millions
Sophiris Bio Inc.  14.48 $ 24.029  Millions$ 1.660  Millions
Aeglea Biotherapeutics, Inc.  14.35 $ 63.393  Millions$ 4.418  Millions
Rexahn Pharmaceuticals, Inc.  13.98 $ 26.807  Millions$ 1.918  Millions
Nivalis Therapeutics, Inc.  13.83 $ 49.497  Millions$ 3.578  Millions
Abeona Therapeutics Inc.  13.82 $ 58.304  Millions$ 4.219  Millions
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GURE's Profile

Stock Price

GURE's Financials

GURE's Expectations

Business Description

Fundamentals

Charts & Quotes

GURE's News

Suppliers

GURE's Competitors

Customers & Markets

Economic Indicators

GURE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com